Gene Expression Profiling Identifies WNT7A As a Possible Candidate Gene for Decreased Cancer Risk in Fragile X Syndrome Patients

Results suggest that this diminished expression of the WNT7A gene may be related to a supposed protection of FXS patients to develop cancer.